NAMES AND DATABASE IDS
NAMES AND DATABASE IDS
Names Database IDs
IUPAC name
|
4-amino-N-(dimethyl-1,3-oxazol-2-yl)benzene-1-sulfonamide
|
|
|
IUPAC Traditional name
|
|
Brand Name
|
Sulfavigor
|
Justamil
|
Sulfmidil
|
Tardamid
|
Vetranal
|
Nuprin
|
|
|
Synonyms
|
Sulphamoxole
|
Sulfamoxol
|
Sulfamoxolum
|
Sulfono
|
Sulfamoxole
|
N1-(4,5-dimethyl-2-oxazolyl)sulfanilamide
|
2-(p-Aminobenzolsulfonamido)-4,5-dimethyloxazole
|
2-Sulfanilamido-4,5-dimethyloxazole
|
Justamil
|
NSC 683535
|
N'-(4,5-Dimethyl-2-oxazolyl)sulfanilamide
|
Oxasulfa
|
Sulfabutin
|
Sulfadimethyloxazole
|
Sulfano
|
Sulfavigor
|
Sulfmidil
|
Sulfune
|
Sulfuno
|
Tardamid
|
Tardamide
|
4-Amino-N-(4,5-dimethyl-2-oxazolyl)benzenesulfonamide
|
N1-(4,5-Dimethyloxazol-2-yl)sulfanilamide
|
Sulfamoxole
|
4-氨基-N-(4,5-二甲基-2-恶唑)苯磺酰胺
|
N1-(4,5-二甲基噁唑-2-基)磺胺
|
磺胺噁唑
|
|
|
CAS Number
|
|
EC Number
|
|
MDL Number
|
|
Beilstein Number
|
|
PubChem SID
|
|
PubChem CID
|
|
CHEBI ID
|
|
ATC CODE
|
|
Chemspider ID
|
|
DrugBank ID
|
|
KEGG ID
|
|
Unique Ingredient Identifier
|
|
Wikipedia Title
|
|
DATA SOURCES
DATA SOURCES
All Sources Commercial Sources Non-commercial Sources
CALCULATED PROPERTIES
CALCULATED PROPERTIES
JChem
ALOGPS 2.1
Acid pKa
|
6.8086896
|
H Acceptors
|
4
|
H Donor
|
2
|
LogD (pH = 5.5)
|
0.57054317
|
LogD (pH = 7.4)
|
0.058534656
|
Log P
|
0.58905804
|
Molar Refractivity
|
67.5145 cm3
|
Polarizability
|
25.918407 Å3
|
Polar Surface Area
|
98.22 Å2
|
Rotatable Bonds
|
2
|
Lipinski's Rule of Five
|
true
|
Log P
|
1.04
|
LOG S
|
-3.0
|
Solubility (Water)
|
2.67e-01 g/l
|
DETAILS
DETAILS
DrugBank
Wikipedia
Sigma Aldrich
TRC
DrugBank -
DB08798
|
Item |
Information |
Drug Groups
|
approved |
Description
|
Sulfamoxole is a sulfonamide antibacterial. |
Indication |
For the treatment of bacterial infection. |
Pharmacology |
Sulfamoxole is a sulfonamide antibiotic. The sulfonamides are synthetic bacteriostatic antibiotics with a wide spectrum against most gram-positive and many gram-negative organisms. However, many strains of an individual species may be resistant. Sulfonamides inhibit multiplication of bacteria by acting as competitive inhibitors of p-aminobenzoic acid in the folic acid metabolism cycle. Bacterial sensitivity is the same for the various sulfonamides, and resistance to one sulfonamide indicates resistance to all. Most sulfonamides are readily absorbed orally. However, parenteral administration is difficult, since the soluble sulfonamide salts are highly alkaline and irritating to the tissues. The sulfonamides are widely distributed throughout all tissues. High levels are achieved in pleural, peritoneal, synovial, and ocular fluids. Although these drugs are no longer used to treat meningitis, CSF levels are high in meningeal infections. Their antibacterial action is inhibited by pus. |
Toxicity |
Oral Rat LD50: > 12500 mg/kg; Intravenous Mouse LD50: 1 g/kg
|
Affected Organisms |
• |
Enteric bacteria and other eubacteria |
|
References |
• |
DUGGER JA: Sulfamoxole (Nuprin), a new sulfonamide, in pediatric practice. J New Drugs. 1961 Sep-Oct;1:223-9.
[Pubmed]
|
|
External Links |
|
|
REFERENCES
REFERENCES
From Suppliers
Google Scholar
PubMed
Google Books
- • DUGGER JA: Sulfamoxole (Nuprin), a new sulfonamide, in pediatric practice. J New Drugs. 1961 Sep-Oct;1:223-9. Pubmed
- • Jaiswal, P., et al.: Talanta, 17, 236 (1970)
- • Saxena, A., et al.: Prog. Drugs Res., 30, 221 (1970)
- Searching...Please wait...
PATENTS
PATENTS
PubChem Patent
Google Patent